These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30611982)

  • 1. Investigation of stereoisomeric bisarylethenesulfonic acid esters for discovering potent and selective PTP1B inhibitors.
    Xie F; Yang F; Liang Y; Li L; Xia Y; Jiang F; Liu W; Qi Y; Chowdhury SR; Xie D; Fu L
    Eur J Med Chem; 2019 Feb; 164():408-422. PubMed ID: 30611982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors.
    Yang F; Xie F; Zhang Y; Xia Y; Liu W; Jiang F; Lam C; Qiao Y; Xie D; Li J; Fu L
    Bioorg Med Chem Lett; 2017 May; 27(10):2166-2170. PubMed ID: 28372909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
    Liu P; Du Y; Song L; Shen J; Li Q
    Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel, potent, selective and cellular active ABC type PTP1B inhibitors containing (methanesulfonyl-phenyl-amino)-acetic acid methyl ester phosphotyrosine mimetic.
    Liu P; Du Y; Song L; Shen J; Li Q
    Bioorg Med Chem; 2015 Nov; 23(21):7079-88. PubMed ID: 26481657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 2-ethoxy-4-(methoxymethyl)benzamide derivatives as potent and selective PTP1B inhibitors.
    Xie F; Liang Y; Xia Y; Luo S; Jiang F; Fu L
    Bioorg Chem; 2019 Nov; 92():103273. PubMed ID: 31539748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
    Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
    Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of 2-substituted ethenesulfonic acid ester derivatives as selective PTP1B inhibitors.
    Liu J; Deng X; Jin Y; Xu B; Liu W; Jiang F; Fu L
    Pharmazie; 2015 Jul; 70(7):446-51. PubMed ID: 26373204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnolia officinalis Extract Contains Potent Inhibitors against PTP1B and Attenuates Hyperglycemia in db/db Mice.
    Sun J; Wang Y; Fu X; Chen Y; Wang D; Li W; Xing S; Li G
    Biomed Res Int; 2015; 2015():139451. PubMed ID: 26064877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein tyrosine phosphatase 1B (PTP1B) inhibitors as potential anti-diabetes agents: patent review (2015-2018).
    Hussain H; Green IR; Abbas G; Adekenov SM; Hussain W; Ali I
    Expert Opin Ther Pat; 2019 Sep; 29(9):689-702. PubMed ID: 31402706
    [No Abstract]   [Full Text] [Related]  

  • 10. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of protein tyrosine phosphatase1B inhibitors defined by binding sites in crystalline complexes.
    Zhang Y; Du Y
    Future Med Chem; 2018 Oct; 10(19):2345-2367. PubMed ID: 30273014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
    Popov D
    Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Methyl artoflavanocoumarin from Juniperus chinensis exerts anti-diabetic effects by inhibiting PTP1B and activating the PI3K/Akt signaling pathway in insulin-resistant HepG2 cells.
    Jung HJ; Seong SH; Ali MY; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2017 Dec; 40(12):1403-1413. PubMed ID: 29177868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of uncharged catechol derivatives as selective inhibitors of PTP1B.
    Li XQ; Xu Q; Luo J; Wang LJ; Jiang B; Zhang RS; Shi DY
    Eur J Med Chem; 2017 Aug; 136():348-359. PubMed ID: 28511130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of geniposide derivatives as potent and selective PTPlB inhibitors.
    Lei S; Zhang D; Qi Y; Chowdhury SR; Sun R; Wang J; Du Y; Fu L; Jiang F
    Eur J Med Chem; 2020 Nov; 205():112508. PubMed ID: 32738350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus.
    Koren S; Fantus IG
    Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    He HB; Gao LX; Deng QF; Ma WP; Tang CL; Qiu WW; Tang J; Li JY; Li J; Yang F
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7237-42. PubMed ID: 23067554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.
    Maheshwari N; Karthikeyan C; Trivedi P; Moorthy NSHN
    Curr Drug Targets; 2018; 19(5):551-575. PubMed ID: 28228082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of lipid-like salicylic acid-based derivatives as potent and membrane-permeable PTP1B inhibitors.
    Li L; Tavallaie MS; Xie F; Xia Y; Liang Y; Jiang F; Fu L
    Bioorg Chem; 2019 Dec; 93():103296. PubMed ID: 31585268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
    Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
    Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.